IPO action brief: SKHY prices, CSQR waits its turn
SK hynix has moved from watchlist to priced status, with a $149 ADS print and strong institutional demand, but no public mainstream retail allocation window was verified. The brief separates trading-watch names from real broker action and keeps Hong Kong no-action for live subscriptions.
SK hynix is no longer just a watchlist item. The Nasdaq ADS deal has a real print: $149 per ADS, 177.9 million ADSs, and roughly $26.5 billion raised. The practical read for retail investors is simple: this is a price-and-trading watch now, not a verified broker allocation window.
July 10 is also a normal NYSE trading day. The NYSE 2026 holiday calendar shows Independence Day observed on July 3, with Labor Day on September 7 as the next full market holiday. 1
Today's Spotlight: SK hynix
SK hynix is one of the world's largest memory-chip companies. Its pitch is easy to understand: AI servers need high-bandwidth memory, and SK hynix says it held 56.4% of the HBM market by revenue in the first quarter of 2026. It also says it ranked second in DRAM with 29.1% share and second in NAND flash with 18.5% share. 2
Why it matters: this is not a tiny concept IPO. It is a mega ADS listing tied to the AI memory trade. IPOScoop says SK hynix priced the Nasdaq uplisting at $149.00, sold 177.9 million ADSs, and raised $26.51 billion on Thursday night, July 9. 3
The headline number: the final price came below the earlier $158.14 reference price shown when terms were first filed, but still represents a large transaction. Futunn, citing Wall Street CN and Bloomberg-based reporting, said the $149 level was about a 3.1% premium to the Seoul closing value and that institutional demand exceeded 7 times the available shares. 4
The key risk: this is still a semiconductor-cycle stock. AI demand is the reason retail investors care, but memory pricing and AI-infrastructure spending can swing fast. Futunn also notes the ordinary shares had pulled back about 25% from a late-June high even while remaining more than double year to date. 4
Subscription status: no mainstream US retail allocation window was publicly verifiable through Robinhood, Fidelity, Schwab, E*TRADE, or Webull in this run. If your broker shows an order ticket, treat that broker screen as the controlling source for deadline, eligibility, and allocation rules.
Actionable Now
No publicly verified mainstream US retail IPO allocation window is open in the sources checked for this issue. That is the main action item: do not confuse a priced IPO, an upcoming IPO, or a calendar listing with a broker allocation window.
| Name | Ticker | Terms | Status today | Retail access read |
|---|---|---|---|---|
| SK hynix | SKHY | $149.00; 177.9M ADSs; about $26.5B | Priced; IPOScoop marks July 10 as priced, while Futunn says pre-trading begins Friday and official listing is July 13 45 | Watch trading and broker availability; no verified public retail allocation window |
| Tarsier Pharma | TARX | 5.0M shares at $8-$10; about $45M | IPOScoop now shows expected trade on July 15 6 | Watch-only unless your broker opens an allocation ticket |
| Csquare | CSQR | 50.0M shares at $23-$27; about $1.25B at midpoint | Expected to trade July 16 7 | Watch for broker access; not confirmed as open today |
| Standard Nuclear | STDN | 18.3M shares at $18-$21; about $355.9M | Expected to trade July 16 5 | Watchlist only |
Market Pulse
- The demand signal is real, but institutional. The strongest buzz item is the report that SK hynix demand exceeded 7 times the offered ADSs. That tells you the book was crowded, not that a retail allocation was easy to get. 4
- Calendar risk moved. Tarsier is no longer the clean July 10 trade-date item in IPOScoop's profile; it now shows July 15. That matters because small biotech IPOs can move around quickly, and retail investors should re-check timing before placing any order. 6
- Next week is theme-heavy. Csquare gives the data-center angle, while Standard Nuclear gives the energy angle. Renaissance Capital lists both in the upcoming-after-this-week group, with Csquare at a $1.25 billion deal size and Standard Nuclear at $356 million. 8
HK Desk
Hong Kong stays no-action for live subscription purposes in this issue. The verified public item was a closed book, not an open application window: Futunn reported that JHICC / NEXCHIP (02249) ran its public offering from June 30 to July 7, with a board lot of 100 shares, an offer range of HK$30.00 to HK$32.30, and expected trading on Friday, July 10. 9
That makes NEXCHIP a listing-watch item, not a subscription action item. If your international broker shows a Hong Kong IPO ticket today, check the close time, refund date, board lot, and listing date inside the broker ticket before acting.
On The Radar
| Name | Ticker | Date to watch | Why retail investors care |
|---|---|---|---|
| SK hynix | SKHY | July 10 / July 13 calendar split | AI-memory leader; priced mega ADS deal; watch first trading behavior and broker access. 3 |
| Csquare | CSQR | July 16 | Data-center infrastructure, 64 sites, 21 metro markets, and about 389 MW of sellable power capacity. 7 |
| Tarsier Pharma | TARX | July 15 | Small clinical-stage biotech; the key risk is binary drug-development execution, not just IPO pricing. 6 |
| Standard Nuclear | STDN | July 16 | Nuclear is a retail-friendly theme, but terms and access still need broker-level confirmation. 5 |
Bottom line: SK hynix is the price print, not a clean retail allocation call. Watch the opening mechanics, keep Csquare on next week's board, and do not treat any IPO as actionable unless your broker shows a real order window. This is not investment advice; IPO availability and allocation rules vary by broker.
References
- 1NYSE holidays and trading hours
nyse.com
- 2SK hynix Form F-1/A
sec.gov
- 3IPOScoop SK hynix profile
iposcoop.com
- 4Futunn SK hynix ADR pricing report
news.futunn.com
- 5IPOScoop IPO calendar
iposcoop.com
- 6IPOScoop Tarsier Pharma profile
iposcoop.com
- 7IPOScoop Csquare profile
iposcoop.com
- 8Renaissance Capital IPO calendar
renaissancecapital.com
- 9Futunn NEXCHIP IPO update
news.futunn.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.